Multidrug Resistant Pneumonia: A Case Study

Pneumonia is an infectious disease, in which the lungs are affected by pathological microorganisms, which are most often bacteria or viruses. As a result of advances in experimental therapeutics, many promising therapies for pneumonia are emerging. The first line agents according to WHO guidelines are penicillins. Many other drugs such as macrolides, carbepenes, tetracyclines, cephalosporines, floroquinolones and aminoglycosides are also used. Some major side effects such as Q-T interval prolongation caused by moxifloxacin and macrolides, tetracycline's cause teeth discoloration, photosentivity, growthretardation, aminoglycosides cause ototoxicity and nephrotoxicity. It's important to note that alteration in doses of drugs used in treatment depending upon individual condition prove helpful in reducing these complications. If a patient is resistant to one drug an alternative drug therapy is suggested or employed.